AR015586A1 - Composicion farmaceutica de residencia gastrica. - Google Patents

Composicion farmaceutica de residencia gastrica.

Info

Publication number
AR015586A1
AR015586A1 ARP980101773A ARP980101773A AR015586A1 AR 015586 A1 AR015586 A1 AR 015586A1 AR P980101773 A ARP980101773 A AR P980101773A AR P980101773 A ARP980101773 A AR P980101773A AR 015586 A1 AR015586 A1 AR 015586A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
gastric residence
carbon dioxide
benzamide
allows
Prior art date
Application number
ARP980101773A
Other languages
English (en)
Spanish (es)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of AR015586A1 publication Critical patent/AR015586A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP980101773A 1997-04-18 1998-04-17 Composicion farmaceutica de residencia gastrica. AR015586A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9704803A FR2762213B1 (fr) 1997-04-18 1997-04-18 Composition pharmaceutique a retention gastrique

Publications (1)

Publication Number Publication Date
AR015586A1 true AR015586A1 (es) 2001-05-16

Family

ID=9506077

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101773A AR015586A1 (es) 1997-04-18 1998-04-17 Composicion farmaceutica de residencia gastrica.

Country Status (19)

Country Link
EP (1) EP0983065A1 (hu)
JP (1) JP2001523241A (hu)
KR (1) KR20010006353A (hu)
CN (1) CN1252720A (hu)
AR (1) AR015586A1 (hu)
AU (1) AU737634B2 (hu)
CA (1) CA2286081A1 (hu)
FR (1) FR2762213B1 (hu)
HU (1) HUP0002455A3 (hu)
IL (1) IL131995A0 (hu)
JO (1) JO2017B1 (hu)
MA (1) MA26482A1 (hu)
NO (1) NO995039L (hu)
NZ (1) NZ500288A (hu)
PE (1) PE68199A1 (hu)
PL (1) PL336273A1 (hu)
TN (1) TNSN98049A1 (hu)
WO (1) WO1998047506A1 (hu)
ZA (1) ZA983258B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
FR2784583B1 (fr) 1998-10-16 2002-01-25 Synthelabo Composition pharmaceutique a residence gastrique et a liberation controlee
FR2790388B1 (fr) * 1999-03-04 2001-04-13 Synthelabo Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
WO2009157711A2 (ko) * 2008-06-24 2009-12-30 Park Eun-Seok 위장체류형 다공성 정제 및 그의 제조 방법
FR2949061B1 (fr) * 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
SI2719376T1 (sl) 2012-10-12 2015-06-30 Omya International Ag Gastrointestinalna zdravilna formulacija in razdeljevalni sistem in njen naäśin priprave z uporabo funkcionaliziranega kalcijevega karbonata
SG11202005016SA (en) 2017-12-05 2020-06-29 Sunovion Pharmaceuticals Inc Nonracemic mixtures and uses thereof
WO2019113084A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
JP7044649B2 (ja) * 2018-06-28 2022-03-30 株式会社ファンケル 胃内浮遊錠剤
KR20220018004A (ko) 2019-06-04 2022-02-14 선오비온 파마슈티컬스 인코포레이티드 조절 방출 제형 및 이의 용도
WO2023214018A1 (en) 2022-05-06 2023-11-09 Galenix Innovations Gastro-retentive swellable sustained release composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415099A1 (fr) * 1978-01-20 1979-08-17 Ile De France Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
JPS62178518A (ja) * 1986-01-30 1987-08-05 Toho Yakuhin Kogyo Kk 新規持続性スルピリド錠剤
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
CA2039742A1 (en) * 1990-04-23 1991-10-24 Andrew B. Dennis Tablet composition and method for problem pharmaceutical materials

Also Published As

Publication number Publication date
AU737634B2 (en) 2001-08-23
PL336273A1 (en) 2000-06-19
NZ500288A (en) 2001-03-30
FR2762213A1 (fr) 1998-10-23
AU7341698A (en) 1998-11-13
NO995039D0 (no) 1999-10-15
NO995039L (no) 1999-12-17
HUP0002455A3 (en) 2001-01-29
WO1998047506A1 (fr) 1998-10-29
MA26482A1 (fr) 2004-12-20
JO2017B1 (en) 1999-05-15
TNSN98049A1 (fr) 2005-03-15
PE68199A1 (es) 1999-07-15
CN1252720A (zh) 2000-05-10
KR20010006353A (ko) 2001-01-26
EP0983065A1 (fr) 2000-03-08
IL131995A0 (en) 2001-03-19
JP2001523241A (ja) 2001-11-20
HUP0002455A2 (hu) 2000-12-28
FR2762213B1 (fr) 1999-05-14
ZA983258B (en) 1998-10-19
CA2286081A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
CY1107675T1 (el) Φαρμακευτικα αλατα τραμαδολης
CY1107841T1 (el) Φαρμακευτικα σκευασματα τα οποια περιλαμβανουν μυκοφαινολικο οξυ ή μυκοφαινολικο αλας
AR015586A1 (es) Composicion farmaceutica de residencia gastrica.
CY1107181T1 (el) Συνδυασμος ζιζανιοκτονων με ακυλιωμενες αμινοφαινυλοσουλφονυλουριες
CY1105154T1 (el) Ενσωματωση δραστικων ουσιων σε μητρες ουσιων-φορεων
ES2051881T3 (es) Procedimiento de preparacion de un formulacion farmaceutica de liberacion prolongada.
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
ES2130423T3 (es) Sistema de administracion intravaginal.
ES2143641T3 (es) Expresion en superficie de una enzima en la terapia genica a base de promedicamentos.
ATE141131T1 (de) Fungizide wirkstoffkombinationen
ES2171416T3 (es) Remedio contra la trombocitopenia.
ECSP034613A (es) Preparacion liofilizada de pantoprazol e inyeccion de pantoprazol
DE60233251D1 (de) 4,4-difluor-1,2,3,4-tetrahydro-5h-1-benzazepinderivate und deren salze
NO171417C (no) Middel for paavisning og bestemmelse av peroksydase-aktivitet, en fremgangsmaate for fremstilling av midlet samt detsanvendelse
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
ME00578A (en) Use of gastrointestinal lipase inhibitors
AR034493A1 (es) Combinacion de principios activos para el tratamiento medico de toxicomanias.
DE59300631D1 (de) Biologisch abbaubare, wässrige Dispersionen.
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
ES2080037T3 (es) Medicamento de uso topico con actividad cicatrizante.
BR9608255A (pt) Sistema terapéutico transdérmico (stt) para a administração de testosterona
CY1105620T1 (el) Περιεκτης για υποδερμικη συριγγα
TR200102024T2 (tr) Yeni tedavi.
MX24039A (es) Composiciones farmaceuticas que contienen una calcitonina como principio activo.
ES2084741T3 (es) Composicion herbicida.